Recent News
Empathetic Nurses Have Positive Impact on Cellular Activity in Pleural Mesothelioma Patients
A mesothelioma diagnosis and the treatment involved take a dramatic toll on the body and the mind, and with no known cure for mesothelioma, it is understandable that many feel…
Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma
This is a phase 1 dose escalation study to characterize the feasibility, safety and tolerability of MCY-M11 when administered as an intraperitoneal (IP) infusion for 3 weekly doses for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, and subjects with peritoneal mesothelioma with recurrence after prior chemotherapy.
Giant Steps Back in the Fight to Ban Asbestos In the United States
Under the Obama Administration, The Toxic Substances Control Act (TSCA) was updated to give the Environmental Protection Agency (EPA) more authority to ban asbestos completely in the United States. The…
DENdritic Cell Immunotherapy for Mesothelioma (DENIM)
This study is to evaluate the overall survival (OS) rate (determined from the time of randomization in the study) Purpose: of subjects who receive dendritic cell immunotherapy with MesoPher plus best supportive care (BSC) compared to BSC alone.
Decrease in Survival Rate Among Those Who Receive Non-traditional Cancer Treatment
Complementary medicine and alternative medicine may sound one in the same, but are vastly different in how each is used, and varying results often make people wary of its true…
New Surgical Technique Illuminates Previously Undetected Mesothelioma Tumors
In addition to chemotherapy, radiation therapy, and immunotherapy, those suffering from mesothelioma also have the option for surgery (if they are physically able). Surgery is one of the better options…
Osimertinib In EGFR Mutant Lung Cancer
This research study is studying a targeted therapy as a possible treatment for Non-Small Cell Lung Cancer (NSCLC) with an EGFR mutation.
The names of the study drug involved in this study is:
– Osimertinib (Tagrisso)
Metal-based Compound May Reduce Tumor Size in Pleural, Peritoneal Mesothelioma
Mesothelial cells are found in the lining of major organs such as the chest or the abdomen. When asbestos fibers are inhaled or ingested, they slice through the soft tissue…
Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer
Primary Outcome Measures Progression free survival [ Time Frame: 1 year ] To evaluate the efficacy of consolidation immunotherapy (Durvalumab) after durvalumab/Etoposide/cisplatin based-CCRT for LD-SCLC Secondary Outcome Measures Overall survival…
Potential Breakthrough in Immunotherapy after Nivolumab Study Results
Immunotherapy treatments have once again made headlines, revolutionizing modern medicine and the way we have come to understand cancer treatment. The latest study results published in the American Journal of…
